Ross Fubini
Managing Partner @ XYZ Venture Capital
San Francisco, United States
Ross Fubini is a seed investor at XYZ Venture Capital in San Francisco focused on Artificial Intelligence and Software. Ross Fubini is based out of San Francisco, California, and is the Managing Partner of XYZ Venture Capital. Ross previously worked at Home Plate Acquisition Corp. as a director. Ross Fubini attended Carnegie Mellon University. Ross Fubini has recognized The Midas Seed List and The Midas List: Top Tech Investors.
- Total investments:
- 73
- Last investment:
- Lead investor:
- 45%
Last updated:
For AI agents: llms.txt
Industries Ross Fubini invests in
Stages Ross Fubini invests in
Countries Ross Fubini invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Artificial Intelligence 12 (16%)
- Software 11 (15%)
- FinTech 8 (11%)
- Health Care 7 (10%)
- Financial Services 7 (10%)
Stage
- Seed 28 (38%)
- Series A 14 (19%)
- Series B 12 (16%)
- Series C 4 (5%)
- Pre-Seed 3 (4%)
Country
- United States 41 (56%)
- United Kingdom 2 (3%)
- Canada 1 (1%)
- Germany 1 (1%)
- Singapore 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Global Sales Tax Compliance Software | $25M / Series A / Jun 30, 2026 | ||
| Frontier Health develops artificial intelligence tools that help healthcare administration teams manage repetitive and high-volume tasks within existing clinical workflows. Its primary product, Juno, functions as an AI coworker that supports care coordination by processing information across multiple patient pathways and software systems. Theplatform is designed to work with a wide range of healthcare applications, enabling organizations to use their current systems while reducing manual administrative work. Frontier Health emphasizes clinical safety, data security, and compliance with healthcare standards, including NHS guidance and information security certifications. The company brings together technology specialists and healthcare professionals with experience working across numerous hospitals to address operational challenges in healthcare delivery. | $12.8M / Seed / Jun 18, 2026 | ||
| Vital Signals is a health innovation business that focuses on one of healthcare's most persistent challenges. | $15M / Seed / May 19, 2026 | ||
| Chapter provides a technology-enabled advisory platform that helps individuals navigate Medicare and retirement-related healthcare decisions. The company offers access to licensed advisors who guide users through plan selection, enrollment timing, and coverage evaluation based on individual needs and preferences. It uses data and software tools tocompare Medicare plans across multiple insurance providers, enabling users to review options and understand cost, coverage, and benefits. It supports decision-making by analyzing plan details and presenting recommendations that align with a user’s healthcare requirements and financial considerations. Its services include ongoing support after enrollment, helping individuals manage their coverage and make adjustments when necessary. The platform also provides digital tools, such as applications for tracking healthcare benefits and accessing over-the-counter allowances.Chapter collaborates with financial institutions, healthcare providers, and content platforms to integrate Medicare guidance into broader client and patient services. It delivers advisory support through partnerships, enabling organizations to offer healthcare coverage guidance as part of their existing offerings. The company combines advisory services with data analysis to simplify complex insurance decisions and assist users in understanding available Medicare options. Its operations focus on improving transparency in plan comparisons and supporting individuals throughout different stages of retirement healthcare planning. | $100M / Series E / Apr 09, 2026 | ||
| ORO Labs develops software that manages procurement workflows through a platform that coordinates business requests, supplier processes, and purchasing activities. The platform connects employees, internal systems, and data sources to guide procurement requests, approvals, and supplier interactions through structured workflows. It provides intakemanagement tools that capture requests and route them through purchasing and finance processes, while supplier onboarding and lifecycle management tools handle documentation, verification, and record updates.The platform includes automation features that support risk checks, compliance validation, and fraud detection during purchasing activities. It also offers configurable workflow tools and an AI agent builder that allows organizations to create automated processes for procurement tasks. ORO Labs integrates with enterprise systems such as ERP, contract management, and financial platforms to support processes from initial request through payment and supplier management. | $100M / Series C / Mar 12, 2026 | ||
| Chariot Defense is developing the sophisticated hardware and software framework to address the military's most pressing problem: the distribution, control, and transformation of energy into power on the contemporary battlefield. | $34M / Series A / Feb 25, 2026 | ||
| Field critical technology faster with an AI platform for government contract capture. | $12.2M / Seed / Dec 08, 2025 | ||
| Cavela automates the process of finding the right supplier and connects you to the entire global manufacturing ecosystem. | $6.6M / Seed / Nov 19, 2025 | ||
| Forterra delivers autonomous mission systems for defense. From self-driving land systems to coordinated swarms of robotic platforms, the company builds scalable, robust, mission-critical hardware and software designed to empower customers to deploy autonomy as a force multiplier - extending reach, survivability, and effectiveness across thebattlespace and industrial domains. | $188M / Series C / Nov 12, 2025 | ||
| Defakto secures the next era of automation with the only complete Non-Human IAM platform, purpose-built for end-to-end NHI lifecycle management. By eliminating static secrets and overprivileged accounts, Defakto helps enterprises reduce breach risk, simplify compliance, and scale automation with confidence. Trusted by Global 2000 companies, Defaktowas founded by leaders in large-scale identity deployments. The platform secures every automated interaction across workloads, pipelines, multi-cloud environments, and AI agents. | $30.8M / Series B / Oct 21, 2025 | ||
| See all 73 investments → | |||
Co-Investors
About XYZ Venture Capital
XYZ Ventures is an early-stage venture capital firm that supports startups build companies in the fintech and insurtech industries.
XYZ Venture Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Chauncey Hamilton
Partner
|
|||
Christine Hubbard
Sr Executive Assistant
|
|||
Ron Bouganim
Limited Partner
|
|||
|
Ross Fubini
Managing Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Ross Fubini invest in?
Ross Fubini invests primarily in Artificial Intelligence, Software and FinTech startups, most often at Seed and Series A stage. Most of the 73 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ross Fubini?
Public channels for Ross Fubini include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Ross Fubini last invest?
The most recent investment recorded for Ross Fubini closed in Jun 2026. Shizune tracks 73 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
